Ethzilla Corp. (ETHZ)

US — Financial Services Sector
Peers: BDCIU  EFTY  LWAC  PLTS  PACH  SVAC  KRSP-UN  GECC  NEWT 

Automate Your Wheel Strategy on ETHZ

With Tiblio's Option Bot, you can configure your own wheel strategy including ETHZ - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ETHZ
  • Rev/Share 0.0167
  • Book/Share 0.9426
  • PB 1.7717
  • Debt/Equity 0.2625
  • CurrentRatio 0.5797
  • ROIC -0.9255

 

  • MktCap 267494124.0
  • FreeCF/Share -0.5534
  • PFCF -84.674
  • PE -1.0355
  • Debt/Assets 0.1318
  • DivYield 0
  • ROE -1.4124

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 3
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

New Ether Treasury ETHZilla Stock Jumps on Buyback Program
ETHZ
Published: August 25, 2025 by: Investopedia
Sentiment: Positive

Shares of ETHZilla (ETHZ) soared 9% Monday as the cryptocurrency treasury firm announced an up to $250 million stock repurchase plan and gave an update on its holding of Ether.

Read More
image for news New Ether Treasury ETHZilla Stock Jumps on Buyback Program

About Ethzilla Corp. (ETHZ)

  • IPO Date 2017-06-27
  • Website https://180lifesciences.com
  • Industry Asset Management - Cryptocurrency
  • CEO Lloyd Blair Jordan
  • Employees 4

ETHZilla operates in digital asset management, gaming, and entertainment. The Company is developing an Ether (ETH) accumulation vehicle to serve as a benchmark for on-chain treasury management among public companies, supported by Electric Capital and a DeFi Council of industry experts. Its strategy targets yield generation beyond traditional ETH staking while advancing gaming initiatives and pursuing monetization of legacy biotechnology assets from its origins as a biotech company.